Mwango Kashoki, MD, MPH | SVP, Global Head of Regulatory Strategy
Parexel

Mwango Kashoki, MD, MPH, SVP, Global Head of Regulatory Strategy, Parexel

A medical doctor, Mwango is an expert in development of analgesic and addiction therapies and post-approval activities (pharmacovigilance, risk management, Phase IV studies). Before joining Parexel in 2018, she spent 16 years with the Food and Drug Administration (FDA), most recently as associate director for safety. She has deep knowledge of review and development of small molecules and biologics, over-the-counter products, and generics. Mwango is board-certified in preventive medicine and public health. She gained her academic training at Johns Hopkins University School of Medicine and the Columbia Mailman School of Public Health. As senior vice president, global head of regulatory strategy at Parexel, Mwango builds and leads multidisciplinary teams to conceptualize and implement projects and programs to advance drug safety science and policy.

Appearances:



Day 1- World Orphan Drug Congress USA 2025 @ 14:00

Roundtable 4: Holistic product planning: Due diligence and early considerations for prioritizing assets and indications

This roundtable will discuss key considerations for building integrated evidence at the earliest stages of development to satisfy the needs of multiple stakeholders. 

Sponsored by Parexel.

last published: 24/Apr/25 11:35 GMT

back to speakers

Get Involved At World Orphan Drug Congress USA

 

Connect with us

 
 
 
 

 

To Sponsor Or Exhibit

 
 

Justin Franks
justin.franks@terrapinn.com
t/ +1 914 819 3506

 

 

 

To Speak

 
 

Kaylee Nguyen
kaylee.nguyen@terrapinn.com
 

 

 

 

Marketing & Press

 
 

Kaylie Brogan
kaylie.brogan@terrapinn.com